Who owns Salix Pharmaceuticals?

Key details on Salix Pharmaceuticals (Ticker: SLXP)

Who owns Salix Pharmaceuticals?

Is SLXP a good stock to own? Find out who bought Salix Pharmaceuticals, who sold Salix Pharmaceuticals (SLXP) stock, and who holds a large position in Salix Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Schroder Investment Management 50.84M $3.40B Sept. 30, 2013
Wellington Management Company 7.06M $870.67M June 30, 2014
FMR 5.40M $844.42M Sept. 30, 2014
BNP PARIBAS ARBITRAGE, SNC 4.12M $614.21M Dec. 31, 2013
Vanguard 3.65M $570.12M Sept. 30, 2014
BlackRock Fund Advisors 2.74M $428.40M Sept. 30, 2014
VIKING GLOBAL INVESTORS 2.72M $424.90M Sept. 30, 2014
TIAA-CREF Investment Management 2.59M $405.30M Sept. 30, 2014
Visium Asset Management 2.30M $359.64M Sept. 30, 2014
Discovery Capital Management 2.19M $88.58M Dec. 31, 2012
Pentwater Capital Management 2.00M $312.48M Sept. 30, 2014
HealthCor Management 2.00M $79.66M June 30, 2011
Damian Sousa 1.87M $125.27M Sept. 30, 2013
STATE STREET CORPORATION 1.84M $287.40M Sept. 30, 2014
HealthCor Management 1.82M $99.35M June 30, 2012
Ameriprise Financial 1.75M $215.28M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.72M $268.73M Sept. 30, 2014
S.A.C. Capital Advisors 1.54M $62.26M Dec. 31, 2012
Oak Ridge Investments 1.38M $92.35M Sept. 30, 2013
TimesSquare Capital Management 1.36M $168.20M June 30, 2014
SUSQUEHANNA INTERNATIONAL 1.30M $203.23M Sept. 30, 2014
Herndon Capital Management 1.28M $84.97M June 30, 2013
Franklin Resources 1.22M $81.83M Sept. 30, 2013
Next Century Growth Investors 1.22M $58.41M Dec. 31, 2011
Teachers Advisors 1.21M $189.64M Sept. 30, 2014
Federated Investors 1.21M $188.51M Sept. 30, 2014
Inves 1.21M $61.73M March 31, 2013
Bank of America Corporation 1.18M $106.35M Dec. 31, 2013

Who sold Salix Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Nicholas Investments Partners June 30, 2011 5.25M $4.46M
Paulson & Co June 30, 2011 1.50M $59.74M
Partner Fund Management March 31, 2011 1.51M $52.72M
OppenheimerFunds Dec. 31, 2010 1.39M $65.42M